Literature DB >> 11710818

Heparan sulfate proteoglycans and cancer.

F H Blackhall1, C L Merry, E J Davies, G C Jayson.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are widely distributed in mammalian tissues and involved in a number of processes related to malignancy. They are composed of a core protein to which chains of the glycosaminoglycan, heparan sulfate (HS), are attached. The existence of various classes of core protein, in addition to highly polymorphic HS chains, creates a superfamily of macromolecules with considerable diversity of structure and function. HSPGs interact with many proteins including growth factors, chemokines and structural proteins of the extracellular matrix to influence cell growth, differentiation, and the cellular response to the environment. The recent identification of two inherited syndromes that are associated with an increased cancer risk, and caused by mutations in HSPG-related genes, has intensified interest in these molecules. This review describes our current understanding of HSPGs in cancer and highlights new possibilities for therapeutic control. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710818      PMCID: PMC2375159          DOI: 10.1054/bjoc.2001.2054

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

Review 1.  Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics.

Authors:  S B Selleck
Journal:  Trends Genet       Date:  2000-05       Impact factor: 11.639

Review 2.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.

Authors:  S S Murthy; T Shen; A De Rienzo; W C Lee; P C Ferriola; S C Jhanwar; B T Mossman; J Filmus; J R Testa
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

4.  Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ.

Authors:  Z Chang; K Meyer; A C Rapraeger; A Friedl
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

5.  Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

Authors:  C Seidel; A Sundan; M Hjorth; I Turesson; I M Dahl; N Abildgaard; A Waage; M Borset
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

6.  EXTL3/EXTR1 alterations in colorectal cancer cell lines.

Authors:  T Arai; Y Akiyama; H Nagasaki; N Murase; S Okabe; T Ikeuchi; K Saito; T Iwai; Y Yuasa
Journal:  Int J Oncol       Date:  1999-11       Impact factor: 5.650

7.  Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.

Authors:  M Veugelers; B D Cat; S Y Muyldermans; G Reekmans; N Delande; S Frints; E Legius; J P Fryns; C Schrander-Stumpel; B Weidle; N Magdalena; G David
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

8.  Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma.

Authors:  M J Stanley; M W Stanley; R D Sanderson; R Zera
Journal:  Am J Clin Pathol       Date:  1999-09       Impact factor: 2.493

9.  Highly sensitive sequencing of the sulfated domains of heparan sulfate.

Authors:  C L Merry; M Lyon; J A Deakin; J J Hopwood; J T Gallagher
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

10.  The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.

Authors:  H Kitagawa; H Shimakawa; K Sugahara
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

View more
  61 in total

1.  Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.

Authors:  Rachel K Okolicsanyi; Anne Buffiere; Jose M E Jacinto; Diego Chacon-Cortes; Suzanne K Chambers; Philippa H Youl; Larisa M Haupt; Lyn R Griffiths
Journal:  Tumour Biol       Date:  2014-11-01

2.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

3.  GPC5 gene and its related pathways in lung cancer.

Authors:  Yafei Li; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

4.  Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2.

Authors:  David H Lum; Jenille Tan; Steven D Rosen; Zena Werb
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 5.  Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.

Authors:  Steven D Rosen; Hassan Lemjabbar-Alaoui
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

Review 6.  Convergent evolution of defensin sequence, structure and function.

Authors:  Thomas M A Shafee; Fung T Lay; Thanh Kha Phan; Marilyn A Anderson; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2016-08-24       Impact factor: 9.261

7.  Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.

Authors:  Tatiana Y Prudnikova; Liudmila A Mostovich; Natalia V Domanitskaya; Tatiana V Pavlova; Vladimir I Kashuba; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cancer Cell Int       Date:  2010-08-19       Impact factor: 5.722

8.  Expression of glypican 3 in placental site trophoblastic tumor.

Authors:  Robin J Ou-Yang; Pei Hui; Ximing J Yang; Debra L Zynger
Journal:  Diagn Pathol       Date:  2010-09-25       Impact factor: 2.644

Review 9.  Syndecan-1: a dynamic regulator of the myeloma microenvironment.

Authors:  Ralph D Sanderson; Yang Yang
Journal:  Clin Exp Metastasis       Date:  2007-11-20       Impact factor: 5.150

10.  Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis.

Authors:  Yi-Huei Linda Jen; Michele Musacchio; Arthur D Lander
Journal:  Neural Dev       Date:  2009-09-04       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.